Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Clinical trial NCT04143217 · COMPLETED

Trial details

NCT number: NCT04143217
Sponsor: Supernus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2020-01-23
Primary completion: 2022-07-26
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.